Learn more about whether Sanofi or Zoetis Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The three drug discovery deals are with Convelo Therapeutics in neurological disorders such as multiple sclerosis, Sosei Heptares for G-protein-coupled receptor-targeting compounds, and Skyhawk ...
It's not the first partnership for Biogen in the RNA splicing area. In 2019, the biopharma teamed up with Skyhawk Therapeutics to try to find small-molecule drugs that could modulate RNA splicing ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval ...
Dyne Therapeutics Inc. 4.43% $1.38B ...
After hours: January 28 at 4:01:40 PM EST Loading Chart for SLNO ...
Sanofi S.A. Part Cert-1.97% €8.03M ...
After hours: 7:59:17 pm GMT-5 ...
After hours: 7:11:56 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback